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The urgent challenges we now face in health can only be met by intelligent, 
co-ordinated responses informed by applied research that builds the 
evidence base for effective health practice focused on public need. 
With the National Institute for Health Research, Policy Research Units, and other partnerships, we are 
developing a research infrastructure that taps into world-class academic resources. 
The London School of Hygiene & Tropical Medicine is a key partner in these initiatives, with the common 
goal to understand and meet these challenges. Through its long-standing collaborative work with 
agencies including Public Health England, and its predecessor the Health Protection Agency, NICE, and 
other NHS and non-governmental health bodies, the School is making many vital contributions to public 
health in the UK and worldwide. 
I am delighted to commend the work of the London School of Hygiene & Tropical Medicine across a wide 
range of expertise, from fundamental laboratory research in infectious diseases and studies of disease 
causation, through development and assessment of novel interventions and services, to advising on 
implementation in real life settings of interventions, service and system reforms, and evaluation that 
informs policy and practice. 
All health systems around the world face similar challenges: whether they 
are the developed ones of the West or the rapidly expanding ones of India 
and China. 
All need to confront the epidemic of so-called non-communicable diseases; all are vulnerable to the same 
risks of global pandemics and the health impacts of social and environmental change; and all need to 
find the best ways to utilise new scientific knowledge and new technologies and engage their populations 
in health promotion and disease prevention. 
The London School of Hygiene & Tropical Medicine has a pivotal role to play. It is extremely well regarded 
and highly influential globally for its work on public health, intervention development and evaluation, and 
health services and systems - in developed and developing countries alike.
From the pioneering studies by Richard Doll and Austin Bradford Hill on smoking and lung cancer, 
research at the School has been central to the development of public health since the inception of the 
NHS. Jerry Morris’s work on physical activity and cardiovascular disease, and subsequently over fifty 
years at the School, had a major influence on government health policy in areas including smoking, air 
pollution and health inequalities.
These are areas in which the School’s work has continued to grow, and this report shows how new 
generations of researchers are sustaining this legacy of methodological innovation to evaluate and 
address contemporary problems.
Our mission is to improve health and health equity in the 
UK and worldwide; working in partnership to achieve 
excellence in public and global health research, education 
and translation of knowledge into policy and practice.
© London School of Hygiene & Tropical Medicine 2013. Cover image and photography by Anne Koerber © London 
School of Hygiene & Tropical Medicine. Additional photography and images courtesy of Helen Warren, iStockphoto, 
stoxk.xchng/Julia Freeman-Woolpert and Thinkstock Getty Images.
At a time of great change and challenge for health systems in 
the UK and globally, many colleagues at the London School of 
Hygiene & Tropical Medicine are engaged in a wide range of 
research programmes which are making vital contributions to health 
outcomes, practice and policy.
Partnership is key to this work, and over the years we have developed productive and valuable 
collaborative links with partners in government, the NHS and its executive agencies, Public 
Health England, local authorities, Royal Colleges, other universities, health policy think-tanks, 
charities and funders such as the Wellcome Trust and Cancer Research UK. 
Today, our School is known as one of the leading centres for research into health services and 
systems in the UK and globally. Our growing Faculty of Public Health and Policy now leads two 
Policy Research Units funded by the Department of Health, is partner in a third, and in 2012 
became a partner in the School for Public Health Research in England established by the NHS 
National Institute for Health Research.
Recent work by the Policy Research Unit in Policy Innovation shows how behaviour 
management techniques, staff and caregiver training and support, are important alternatives 
to anti-psychotics for managing behavioural and psychological symptoms in patients 
with dementia. In collaboration with the Royal College of Surgeons, we run their Clinical 
Effectiveness Unit, and have successfully managed several national clinical audits. We 
have recently established a similar partnership with the Royal College of Obstetricians and 
Gynaecologists.
Together with our Faculties of Epidemiology and Population Health, and Infectious and Tropical 
Diseases, the School’s expertise encompasses doctors, epidemiologists, statisticians, 
sociologists, anthropologists, psychologists, historians, economists and health policy experts.
Over the next three years we are committed to build on our current partnerships and develop 
new ones. This publication offers a brief overview of some of the work we are doing in the UK, 
and the ways in which we are making a difference. I hope you will be inspired to join us in this 
effort.
Peter Piot 
Director, London School of Hygiene & Tropical Medicine
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Policy Research in 
Commissioning and the 
Healthcare System
The new Policy Research Unit in 
Commissioning and the Healthcare System, 
a partnership between the School with the 
University of Manchester and the Centre for 
Health Services Studies at the University 
of Kent, led by Stephen Peckham and 
Pauline Allen, works with the Department 
of Health to inform the development of 
policy on commissioning, and how it can 
improve services and access, and increase 
effectiveness and respond better to patient 
needs. 
Current research programmes include an 
evaluation of the commissioning strategies 
and impact of Clinical Commissioning 
Groups, empirical research on the use of 
contractual mechanisms in commissioning, 
a review on clinical engagement in primary 
care commissioning. The Unit has also 
supported the Department of Health 
Commissioning Policy Group on policy 
development around Personal Health 
Budgets, and is exploring the relationship 
between primary care expenditure, 
outcomes and overall NHS expenditure, and 
investigating the use by commissioners of 
competition and co-operation as strategies 
in local health systems. 
Economic assessments for 
NICE guidance 
The UK’s National Institute for Health and 
Clinical Excellence (NICE) was established 
in 1999 to provide robust and authoritative 
recommendations to the NHS on the use 
of a wider array of health care interventions 
and treatments. In collaboration with the 
National Collaborating Centre for Cancer, 
John Cairns and Alec Miners led a team 
responsible for the economic assessments 
contained within all of NICE cancer related 
guidelines, including those for prostate, 
early and advanced breast cancer. They 
continue to serve on the NICE Technology 
Appraisal Committee, which meets monthly 
to review evidence on the clinical and 
cost-effectiveness of health technologies, 
particularly new drugs. The guidance issued 
by the committee is vital both for the NHS 
and also a significant input to decision 
making in many other countries. 
Pilot and demonstration programmes are 
vital to inform the early stages of policy 
development. Established in January 
2011, the Policy Research Unit in Policy 
Innovation Research, led by Nicholas 
Mays, Mark Petticrew and Bob Erens, is 
a collaboration between the School and 
partners including the London School of 
Economics and Imperial College London. 
The Unit brings together health and social 
care research expertise to support and 
improve evidence-informed policy-making 
across NHS, social care and public health 
policy at national level. 
The Unit is currently evaluating a range 
of policy pilot projects including: patient 
choice of general practice, cold weather 
alerts for patients with chronic lung 
disease and direct payments in social care. 
We are also engaged in methodological 
work designed to improve the quality and 
applicability of policy and programme 
evaluations, such as the identification of 
comparison groups for quasi-experimental 
evaluations. 
Health reform, services & systems improvement
Improving care through 
patient reported outcome 
measures 
How can we improve patient care before and 
after surgery? Nick Black and colleagues 
designed and developed a pioneering 
programme, the largest of its kind in 
the world, to collect and analyse patient 
reported outcome measures (PROMs). All 
250,000 patients undergoing a hip or knee 
replacement, hernia repair or varicose vein 
surgery in the NHS in England each year 
are asked to report their state of of health 
before and after to determine the benefit. 
School researchers are now analysing 
the data to understand and compare the 
performance of hospitals and make it useful 
for the public, clinicians, managers and 
policy-makers.
Reducing preventable 
hospital deaths 
There are almost 12,000 preventable 
deaths in hospital in England every year 
due to problems with care, however 
this is less than a third of the number 
previously thought. According to a recent 
study, published in BMJ Quality and Safety, 
researchers Helen Hogan and Nick Black 
found the majority of poor care associated 
with preventable deaths was the result of 
poor monitoring of the patient’s condition, 
wrong diagnosis or errors in medication 
or fluid replacement. However, as only 
5% of deaths in hospital are preventable, 
mortality rates are statistically inappropriate 
as an indicator of care quality, and this 
has implications for the way care quality is 
assessed in the NHS. 
National clinical audit: 
working with Royal Colleges 
The School’s Health Services Research 
and Policy Department has ongoing 
collaborations with several Royal Medical 
Colleges to examine the process and 
outcomes of care within the NHS. The 
Clinical Effectiveness Unit at the Royal 
College of Surgeons of England was 
established in 1998, while the collaboration 
with the Royal College of Obstetricians 
and Gynaecologists was established in 
2006, to undertake projects as part of the 
Government’s National Clinical Audit and 
Patient Outcomes programme. 
For example, the Mastectomy and Breast 
Reconstruction audit recently found that one 
in five women treated in England between 
2008-09 had breast reconstruction at 
the time of their mastectomy, compared 
to one in nine women in 2006. However, 
the proportion of women who underwent 
immediate reconstruction varied widely 
across different regions of England. A study 
on caesarean section rates among English 
NHS hospitals showed that most variation 
in these rates of caesarean section was 
associated with emergency caesarean 
section, which reflects that the variation 
is due to how clinicians respond to acute 
situations due to labour rather than the 
preferences of women.
School for Public Health 
Research: Evidence for 
decision making in local 
government 
With the abolition of Primary Care Trusts, 
local authorities are now responsible for 
public health, with guidance from NICE, 
and this change will potentially have major 
impacts across England.
As partners in the NIHR-funded School for 
Public Health Research, we are working 
with policy-makers and practitioners in 
local government to develop new evaluative 
research to support action on social 
determinants of health. Karen Lock, Mark 
Petticrew and colleagues are researching 
how decisions are made and policies 
implemented across a range of policy 
sectors including regeneration, housing, 
transport, crime and alcohol licensing. 
As well as exploring how policymakers 
understand and use evidence, the team is 
working on methods involving public health, 
local government and other stakeholders in 
evaluating their work based on their needs. 
The aim is to design and conduct research 
appropriate to local decision making 
processes, thus increasing the value of 
research for policy and practice. The School 
is also a partner in the Mayor of London’s 
‘Fit Cities’ initiative.
 
Research on diversity of 
providers to NHS patients
One of the key aspects of the Health 
and Social Care Act 2013 is the policy 
of broadening the types of provider of 
healthcare to NHS patients to include 
organisations which are not part of the NHS 
itself; and to encourage those organisations 
which remain in the NHS to increase their 
autonomy by becoming NHS foundation 
trusts.
Pauline Allen, working 
with colleagues at Bristol 
and Leeds Universities, 
is undertaking a series 
of studies funded by the 
National Institute for Health 
Research (NIHR) to examine 
the extent, nature and effects 
of increasing the diversity of 
providers. 
Their findings to date suggest 
that while NHS Foundation Trusts have 
been able to make service developments 
more quickly, participation by for-profit 
organisations has been low. Non-profit 
organisations including social enterprises 
have concentrated on particular sectors 
of care, such as community services and 
services for minority or marginalised groups. 
The School leads a number of major research programmes designed to help improve the quality, 
organisation and management of health services and systems. This encompasses developing methods 
for assessing the quality of health care providers, evaluating the organisation and delivery of health 
care, and national and international policies on funding, workforce planning and governance. 
There is good evidence that patients, 
particularly those with long term conditions, 
benefit from involvement in their own care. 
The Engagement and Voice in 
Commissioning project is a 3-year study 
funded by the National Institute of Health 
Research to investigate how patients 
and the public are involved in local 
commissioning of services, and how 
health organisations, including Clinical 
Commissioning Groups, engage with service 
users and enable their voices to be heard. 
From 2010 to 2013, researchers 
worked with over 90 patient groups, 
commissioners, health care professionals 
and individual patients in three sites 
across England, focusing on diabetes, 
neurological conditions, and rheumatoid 
arthritis. The team found well-developed 
strategies and structures for Patient and 
Public Involvement, however these tend to 
be driven by the organisational agendas 
of commissioners and providers. The 
authors identified the need to acknowledge 
better expressive narratives of the patient 
experience alongside purposive-rational 
relationships between commissioners and 
patients. 
Improving the effectiveness of pilot projects
Engagement and Voice in Commissioning 
The Olympics and 
regeneration in East 
London 
What is the long-term legacy for health of 
the London 2012 Games and associated 
urban regeneration? A major five-year 
project led by Steven Cummins with 
colleagues at Queen Mary, University of 
London and University of East London, 
will explore whether and how social 
factors for health and well-being among 
local residents have improved as a 
result of new facilities, job opportunities, 
transport infrastructure, green spaces 
and other improvements to promote 
healthy living. 
Funded by NIHR, the Olympics and 
Regeneration in East London (ORIEL) 
project began early in 2011, with 
researchers collecting baseline data from 
around 3,000 children (aged 11-12) and 
their parents. Participants were followed 
up early in 2013, six months after the 
Games. Focusing on health, well-being, 
physical activity, socioeconomic factors 
and residents’ perceptions of the impact 
of local changes, the findings are being 
compared with data collected from 
nearby urban areas outside the Olympic 
regeneration zone. The participants 
will be followed up again early in 2014 
and will form a cohort for a longitudinal 
study of how any socio-economic and 
health impacts are sustained over time.
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Txt2stop rolled out as 
national smoking cessation 
programme
Smokers are twice as likely to succeed in 
quitting when they receive encouraging 
text messages, according to the findings 
of a major randomised controlled trial 
led by Caroline Free, Senior Lecturer in 
Epidemiology at the School and a 
London GP.
The txt2stop study examined 
the long-term effects of specially-
designed mobile text messages on 
5,800 volunteer participants, and confirmed 
reported cessation after six months by 
testing saliva.
Published in The Lancet, the study was 
named Research Paper of the Year by the 
Royal College of General Practitioners and 
Novartis, the Medical Research Council 
and Bupa Foundation Healthy Lives Prize. 
Free worked with the Department of Health 
to roll out the programme as a service to 
smokers across England, and since the 
launch of the service in January 2012, more 
than 50,000 people have received smoking 
cessation support. The results of the trial 
have led researchers in Sweden, USA, India 
and Italy, and the World Health Organization 
to develop local smoking cessation support 
programmes delivered by text message.
Public health, lifestyle & environment
What works in weight 
control?
The effectiveness of local interventions 
by GPs was recently demonstrated in the 
Camden Weight Loss programme. Kiran 
Nanchahal and colleagues from the School 
worked in partnership with GPs and health 
centres to conduct a randomised controlled 
trial of a one-to-one lifestyle intervention 
delivered in UK general practice to 
overweight and obese patients. 
Following 381 adult participants over a year, 
the team monitored changes in weight, 
body fat, blood pressure and heart rate. 
They found that a clinically important level 
of weight loss was achieved by a higher 
proportion of intervention participants, who 
also reported higher level of satisfaction 
with support received. However, they 
concluded that primary care interventions 
are unlikely to be sufficient to tackle the 
obesity epidemic; effective population-wide 
measures are also necessary. 
Transport and health 
Increasing regular physical activity is a key 
public health goal. One strategy is to change 
the physical environment to encourage 
walking and cycling, requiring partnerships 
with the transport and urban planning 
sectors.
The School’s Transport and Health Group 
has recently worked on several high-profile 
studies for the World Health Organization 
on road traffic injury prevention, and for 
the UK Department for Health on accident 
prevention strategy. With Transport for 
London they have conducted three studies 
into road safety, focusing respectively on 
deprivation, minority ethnic groups, and 
evaluation of traffic calmed 20mph zones. 
Other recent projects have included an 
international collaboration, funded by the 
Wellcome Trust, to provide evidence on the 
health effects of climate change mitigation 
for the 2009 UN Climate Change conference 
in Copenhagen and a study funded by 
Camden Primary Care Trust and Transport 
for London focused on cycle commuting.
On The Buses: What are the effects of 
free bus travel for older people and for 
young people on health and wellbeing? 
The Transport and Health group at the 
School, in collaboration with the Institute for 
Child Health and University of Leeds, has 
evaluated the impacts of the scheme on 
public health. Overall, the studies found a 
range of positive effects on the wellbeing of 
both age groups through increased mobility, 
independence, social interaction and 
physical activity.
LANTERNS study launched to shed light on 
safety: Many councils in England and Wales 
are switching off or dimming street lights 
at night in order to save money and energy, 
and reduce light pollution. The Transport 
and Health group is currently collecting and 
analysing data on locations of crimes and 
road traffic crashes across the country to 
provide evidence of the impact of reduced 
street light schemes on these important 
public health outcomes.
Air pollution linked to 
increased deaths following 
heart attacks
Patients recovering from heart attacks are 
less likely to survive if they live in an area 
with high levels of road traffic pollution. 
Comparing air pollution data with the records 
of over 150,000 acute coronary patients 
in England and Wales, researchers Cathryn 
Tonne and Paul Wilkinson found that death 
rates after leaving hospital were higher 
among patients who lived in areas with 
increased exposure to particulate matter 
emissions from road traffic and industry. 
Published in the European Heart Journal in 
Feb 2013, the results show that patients 
living in London had the highest exposure 
to air pollution levels, and that patients 
from poorer backgrounds were more at 
risk. Overall, they estimated that exposure 
accounts for 12% of early deaths among the 
group - around 4,800 people. 
Walking and cycling: WHO 
health economic assessment 
tool (HEAT)
How can policy makers put a value on the 
health benefıts of active travel? Economic 
evaluation is an important factor in the 
decision to fund any new transport scheme, 
but without good techniques for assessing 
the health benefıts of cycling and walking, 
these are widely under-valued. 
Harry Rutter and colleagues have developed 
a transparent, easy to use and reliable tool 
for transport planners and economists to 
properly incorporate the health benefits 
of walking and cycling into transport 
appraisals. The approach has been adopted 
by the UK Department of Transport in its 
official appraisal guidance, and it is being 
considered in a number of other countries 
including Sweden. 
Drugs, alcohol and tobacco, 
past and present
Drug use and addiction, particularly alcohol 
and tobacco, have been with us throughout 
history and today pose major public health 
challenges worldwide. The School’s Centre 
for History in Public Health conducts 
influential work in this area and is currently 
involved in the wide-ranging EU framework 
initiative on addiction. Virginia Berridge 
leads the Addiction through the Ages project, 
researching approaches to and concepts 
of addiction. In June 2013, the Centre is 
hosting an international conference on the 
history of alcohol and drugs at the School. 
The History Centre also conducts research 
on public health and health services. A 
new Wellcome investigator award to Alex 
Mold focuses on the role of ‘the public’ 
in public health since World War II, while 
Martin Gorsky is investigating The Wellcome 
Library’s digitised Medical Officer of Health 
reports. The Centre runs a popular series 
of public health history walks and film 
screenings, and its research has various 
impacts on policy through briefings for local 
government, and nationally through evidence 
to the Parliamentary Committee on Health. 
Health is profoundly affected by behavioural and environmental factors which operate at individual, 
community and population scales. While the extent to which health outcomes and inequalities are 
the result of societal pressures or personal choice is open to political debate, increasingly sedentary 
lifestyles, car use and over-nutrition have caused growth in obesity and related health problems.
The challenges are huge, yet there are interventions which are known to be effective, for example on 
tobacco, sugar, fat and alcohol reduction, and increased physical activity. Public health evaluations 
related to these, sexual health, the built environment and air quality, are rapidly expanding areas of 
work at the School. In order to evaluate such complex social interventions, it is vital to ensure that 
methodologies are sound, and that the outcomes of local trials can be efficiently scaled up.
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Infectious disease monitoring & control
Shaping policy on vaccines 
and immunisation
John Edmunds and colleagues in the Centre 
for the Mathematical Modelling of Infectious 
Diseases have been working with the 
Health Protection Agency for several years, 
predicting the course of epidemics and the 
impact of vaccination programmes. This 
work has informed UK policy on pandemic 
influenza, and many UK-specific policy 
decisions through the Joint Committee on 
Vaccination and Immunisation, chaired by 
Andy HalI. Recent examples include the 
effectiveness and cost-effectiveness of 
pneumococcal conjugate vaccines, rotavirus 
vaccination, and the decision to introduce 
annual influenza vaccination in children.
Hospital for Tropical Diseases 
& Malaria Reference Lab 
The School has been host to the UK 
Malaria Reference Laboratory since its 
inception in the 1970s. It works with Public 
Health England to gather malaria samples 
and collate national data on the travel 
histories and prophylaxis use patterns 
among UK travellers with malaria. This then 
informs treatment and prophylaxis policy 
recommendations made to travel clinics and 
health workers across the country.
Infectious diseases do not recognise 
national borders, and scientists at the 
School are working with colleagues at 
the Hospital for Tropical Diseases, Public 
Health England and the Blood Transfusion 
Service to maintain vigilance so that blood 
donations used to treat patients across the 
UK are free from a range of parasites. These 
include the causative agents of malaria, 
trypanosomiasis, leishmaniasis, babesiosis, 
toxoplasmosis and Chagas’ disease.
Hand-washing and health 
Val Curtis, director of the School’s Hygiene 
Centre, leads the UK campaign for Global 
Handwashing Day, which has had a major 
impact on awareness of hygiene issues in 
recent years. In 2012, a nationwide study 
carried out by researchers from the School 
and partners from Queen Mary, University 
of London, investigated levels of bacterial 
contamination on the hands, credit cards 
and currency of various sample sizes in 
East and West London, Birmingham and 
Liverpool. They found that 11% of hands, 
8% of cards and 6% of notes showed gross 
contamination– where the levels of bacteria 
detected were equal to what you would 
expect to find in a dirty toilet bowl, and 
these results were widely reported in global 
media.
Ensuring efficiency in HIV 
therapy
Around 3,500 new HIV infections 
occur each year in the UK, 
and this continues to increase 
despite intensive prevention 
efforts. Effective antiretroviral 
therapy (ART) enables people 
to live with HIV, but care is 
expensive – an estimated 
£1.75 billion in future drug 
costs alone. People on ART 
with a low viral load have markedly reduced 
infectiousness, but the extent of this is 
uncertain. Working in partnership with 
UCL, funded by the NIHR, Alec Miners is a 
co-investigator on the ASTRA project with 
the aim of establishing the links between 
sexual risk behaviour and attitudes to 
HIV transmission. The overall objective is 
to assess the effectiveness and cost-
effectiveness of immediate rather than 
deferred ART treatment from a UK NHS 
perspective. 
Flusurvey, pandemic flu 
surveillance
UK Flusurvey is run by the School as part of 
InfluenzaNet,the Europe-wide programme to 
monitor the activity of ‘flu-like illness, with the 
aid of volunteers via the internet. 
While reports of seasonal flu are still at a 
low level, early analysis of data collected so 
far from the 2012-13 survey reveals that 
reports of flu-like illness are highest among 
children, and that women report more 
flu-like symptoms than men overall. With 
over 5,000 people taking part in the weekly 
survey, Flusurvey.org.uk allows people 
to report their symptoms directly and the 
data are supplied to the Health Protection 
Agency (now Public Health England) national 
surveillance programmes. 
Global events and mass 
gatherings medicine 
David Heymann was awarded a Research 
Councils UK Podium Award for exceptional 
research contribution, for work on mass 
gatherings and infectious disease prevention 
in advance of the London 2012 Games, 
with Brian McCloskey, London Regional 
Director and Olympics lead at the Health 
Protection Agency. The School recently 
hosted a speaker meeting and public panel 
discussion on the health and medical issues 
around global mass gatherings and major 
sporting events. 
Partners and participants included Chatham 
House, the Institute of Global Health 
Innovation at Imperial College London, the 
Health Protection Agency, The London 2012 
organising committee, and the World Health 
Organization. David Heymann and colleagues 
in Europe, Asia and the USA are now working 
on developing health policies concerning 
mass gatherings, and how international 
collaboration can increase resilience in 
future.
While we have achieved great success in infectious disease control through improved hygiene, 
sanitation and widespread use of antibiotics, we are now experiencing the emergence of new resistant 
strains of bacteria, as well as the resurgent threat of pandemic viruses. The UK, and particularly its 
major cities, are now global, and increased movement of people, both through migration or tourism, is 
exposing more people to pathogens.
The School is a leading centre for research in infectious disease worldwide, and in London is now 
engaged in a partnership with University College London to develop the new Bloomsbury Research 
Institute, a centre for translational research with a mission to seek new diagnostic tools, treatments 
and vaccines, and focus on hospital-acquired infections, which cause thousands of deaths and are a 
growing challenge to hospitals in the UK. 
Mapping Disease: The legacy of John Snow
John Snow (1813–1858) is an iconic figure in epidemiology and public health, best 
known for his pioneering work tracing the source of a deadly outbreak of cholera to a 
water pump in Soho, London. In collaboration with the Wellcome Trust, the International 
Epidemiological Association and the John Snow Society, the School is running a 
programme of events throughout Spring 2013 to celebrate his achievements and the new 
research that continues his legacy. Speakers include Lord May, Sir Mark Walport and Ben 
Goldacre, Wellcome research fellow in epidemiology at the School.
The BCG (Bacillus Calmette-Guerin) vaccine 
has been used to prevent Tuberculosis 
since 1953. Until autumn 2005, the BCG 
vaccine was routinely given to all 13-year old 
schoolchildren in the UK, and more recently 
it has been offered in infancy. However, it is 
not known how long the protection afforded 
by the BCG vaccine lasts, particularly 
in different age and population groups, 
hindering the development of evidence-based 
policies for immunisation. 
Working with the Health Protection Agency, a 
team at the School, led by Laura Rodrigues 
and Punam Mangtani, are conducting two 
national observational studies to evaluate 
how long the BCG vaccine given at either 
ages has an effect on preventing ill-health. 
They are also assessing factors affecting 
effectiveness of the delivery of BCG vaccine 
and have recently published in BMJ Open a 
survey of how BCG vaccine policy is working 
at the local level. 
Hazel Dockrell and colleagues at the 
School’s immunology and infection 
department have been studying immune 
responses induced by BCG vaccination in the 
UK for over 15 years. Initially they compared 
immunity induced in UK adolescents with 
that induced by BCG in northern Malawi. 
Since 2005, BCG has been given to infants 
in areas with a rate of TB over 40/100,000. 
They found that vaccinated infants in two 
London boroughs (Redbridge and Waltham 
Forest) have much stronger T-cell responses 
following BCG vaccination than infants in 
Malawi. This work is contributing to the global 
effort to develop biomarkers that could be 
used in TB vaccine trials and is funded by 
two EU research consortia. 
The group is also using patients being tested 
for helminth worm infections in London to 
study how these infections might affect 
immunity to TB. Researchers are working 
with patients presenting to the Hospital 
for Tropical Diseases at University College 
Hospital both before and after treatment 
of their worm infections. These parasites 
induce regulatory T cells that have a negative 
impact on immunity to TB, but treatment 
allows recovery of these responses. 
Visit our TB Centre website
TB: evaluating effectiveness of BCG vaccines at population and immunological level
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Factors affecting lung 
cancer survival
Lung cancer survival in the UK is lower than 
in six comparator countries, according to a 
new international study carried out by the 
Cancer Research UK Survival Group at the 
School. While Sweden had the highest rate 
of one-year survival from the most common 
form of the disease (non-small cell lung 
cancer) at 46%, the UK ranked lowest at just 
30%. 
The research, for the International Cancer 
Benchmarking Partnership, included over 
57,000 patients, looking at their stage 
at diagnosis and what proportion of them 
lived for more than a year. The study 
suggests that late diagnosis contributes 
to low survival - only one in seven patients 
were diagnosed at the earliest stage of 
the disease in both the UK and Denmark, 
compared with one in five elsewhere. The 
group has recently found that late-stage 
breast cancer survival is also lower for 
women in the UK than other comparable 
countries, and there have been calls for an 
investigation into whether treatment meets 
international standards. 
Testing for HPV (human papillomavirus) 
is likely to replace the cervical smear 
test in primary cervical screening, but 
the most cost-effective way to implement 
this is unclear. HPV infection affects 
around 40% of young women in the UK, 
making it vital to ensure primary HPV 
screening is both effective and efficient. A 
Randomised Trial In Screening To Improve 
Cytology (ARTISTIC), led by Julian Peto 
and Clare Gilham, compared cytology 
alone and cytology combined with HPV 
testing in over 24,000 women in Greater 
Manchester. The trial showed that women 
who were negative for HPV infection had 
a significantly lower cumulative rate of 
cervical pre-cancer over 6 years than 
women with a negative smear, and that 
HPV primary screening would therefore 
provide a longer interval of protection than 
cytology. ARTISTIC data are currently being 
combined in a meta-analysis together with 
3 other large European trials to investigate 
the efficacy of HPV-based screening in 
preventing invasive cervical cancer.
Non-communicable diseases: diagnosis & care
Dementia and quality of life: 
working with patients and 
carers
The estimated 800,000 people with 
dementia in England is expected to increase 
rapidly as the population ages. Until we 
can effectively prevent and treat dementia, 
there is a pressing need to determine the 
most effective and cost-effective ways of 
caring for people with dementia and their lay 
carers. From June 2013, Sarah Smith and 
Nick Black in the School’s Health Services 
Research & Policy Department, working 
with The Alzheimer’s Society, are leading 
a programme to develop ways of routinely 
assessing the quality of life of patients and 
their carers. Then, in two nationwide studies, 
they will evaluate memory assessment 
services (memory clinics) and the impact 
of stopping the use of anti-psychotic 
drugs - treatment that is no longer seen as 
appropriate. 
Vitamin D to prevent 
morbidity and mortality
A growing body of evidence suggests 
that high doses of vitamin D decrease 
cancer incidence and mortality as well as 
cardiovascular mortality. Julian Peto and 
colleagues are initiating a randomised 
feasibility study of 1,600 people registered 
with a GP practice to precede a much 
larger VIDAL (Vitamin D and Longevity) Trial 
of 20,000 people aged 65-84. Outcome 
measures will be cause-specific mortality 
and cancer incidence, hospital admissions 
ascertained by flagging or tracing in national 
record systems, and reasons for any 
hospital admissions.
Dietary salt and 
cardiovascular disease
The number of people in England adding 
salt to food at the table fell by more than a 
quarter in five years, according to work by 
Alan Dangour and colleagues, published in 
Jan 2013 in the British Journal of Nutrition. 
The researchers looked at salt intake from 
1997-2007 in large nationally-representative 
samples of more than 6,000 adults living 
in England. They found that since the 
campaign launched in 2003, the proportion 
of people reporting that they add salt at 
the table dropped from 32.5% to 23.2% in 
the following five years. Women were less 
likely to add salt at the table, as were those 
from younger age groups, higher income 
households and non-white ethnic groups.
The increasing burden of non-communicable diseases such as cancers, cardiovascular disease, 
diabetes and mental illness, poses an enormous threat to populations and health systems across 
the globe. The School’s diverse expertise in non-communicable disease prevention and control was 
in 2012 brought together in the Centre for Global Non-Communicable Diseases, to strengthen and 
promote research contributing to health policy. The School also hosts the Cancer Research UK Cancer 
Survival Group, and within the Department of Social and Environmental Health Research, there is a 
programme of research examining effects of air pollution on cardiovascular disease outcomes, and 
elucidating environmental links between socio-economic factors and heart disease.
Improving cervical screening for HPV and cancer
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Sexual health, equality & access
biomedical measures enabling estimates 
of the prevalence of Chlamydia in the 
population for the first time.
The third national survey, in 2010, 
conducted by the School in partnership with 
the National Centre for Social Research 
and University College London, and funded 
by the Medical Research Council, the 
Economic and Social Research Council and 
the Wellcome Trust, is considerably more 
ambitious. The sample spans an age range 
of 16-74, the study incorporates a qualitative 
component, and biomedical measures 
include not only testing for an expanded 
range of sexually-transmitted infections but 
also the measurement of testosterone in 
the general population, using a uniquely 
validated salivary assay. The first tranche of 
papers, published in December 2013, will be 
followed by a comprehensive dissemination 
strategy aimed at providing information with 
which to shape policy to improve sexual 
health. 
With increasing rates of sexually transmitted infections, sexual activity and teenage pregnancies, 
understanding the factors shaping sexual behaviour is more important than ever for improving young 
people’s sexual health and wellbeing. 
In the mid-1980s, little was known about 
the sexual attitudes and lifestyles of people 
in Britain. In 1987, Kaye Wellings and 
colleagues founded the National Survey of 
Sexual Attitudes and Lifestyles (Natsal). 
The first survey in 1990 provided data 
which were used to help predict and prevent 
further transmission of HIV in Britain. The 
second survey in 2000 looked at changes 
in behaviour over the previous decade and 
had a broader remit, exploring patterns and 
trends in reproductive health and including 
National Survey of Sexual Attitudes and Lifestyles
Migration, trafficking & access to services 
HIV Prevention England, 
monitoring and evaluation
Sigma Research is one of six partners 
making up HIV Prevention England, funded 
by the Department of Health. It runs the 
Gay Men’s Sex Survey and Bass Line, two 
well-established periodic community surveys 
assessing the HIV prevention needs of gay 
men and African communities respectively. 
Sigma has also led the development of 
Making it Count and The Knowledge, the 
Will and the Power – the HIV prevention 
frameworks that have guided UK HIV 
prevention work with gay men and African 
communities in recent years. 
Within HIV Prevention England, Sigma 
focuses on monitoring and evaluating 
activities carried out by 40 Local Delivery 
Partners. These range from condom 
distribution and the placement of advertising 
to lobbying and local authority engagement. 
In some cases, it will be possible to analyse 
what works before and after intervention, 
and in other cases, behavioural surveys 
provide insights into how knowledge, 
attitudes and behaviour change as a result 
of these interventions.
The School is also a partner in the European 
Men who have Sex with Men (MSM) Internet 
Survey (EMIS) a joint project of academic, 
governmental, non-governmental, and online 
media partners from 35 European countries 
to inform interventions for gay, bisexual, and 
other men who have sex with men, a group 
highly affected by HIV and other sexually 
transmitted infections.
Sex and health: what young 
people think and do 
The sixteen18 project, conducted by Cicely 
Marston, Ruth Lewis and Kaye Wellings 
examines a broad range of practices, 
including mutual masturbation, oral sex, 
vaginal and anal intercourse. Based 
on interviews with 130 young men and 
women aged 16-18 in England, the study 
aims to understand where, when and with 
whom young people would expect different 
practices to occur, and 
what those practices 
mean to them. 
The study’s 
findings show 
continuing 
inequities 
in sexual 
interactions 
between young men 
and women, with young 
women’s coercion into anal 
intercourse a particular problem. 
They also show how young people’s ideas 
about what practices are ‘risky’ are often 
at odds with those of health professionals. 
Young women, for example, often see 
vaginal intercourse as a less risky option, 
despite the higher likelihood of pregnancy 
and sexually-transmitted infections 
transmission.
Thousands of people from all over the 
world are trafficked to the UK for forced 
sex work, domestic servitude, and labour 
in agriculture, manufacturing and service 
industries. Trafficked men, women and 
children frequently experience extreme 
physical, psychological and sexual violence 
and social marginalisation, and many 
suffer from acute and long-term health 
problems, and little is currently known 
about their healthcare needs, how they 
access NHS services and how to help 
healthcare professionals respond.
Cathy Zimmerman and her colleagues 
at the School’s Gender, Violence and 
Health Centre are leading research in 
this challenging field. They conducted 
multi-country research on the health 
of trafficked women and adolescents, 
which generated the first-ever data on the 
health risks and outcomes associated 
with trafficking. Dr Zimmerman is the 
author of the World Health Organization’s 
Recommendations for Interviewing 
Trafficked Women, and other international 
resources for law enforcement, service 
providers and health professionals.
The Centre is working with partners 
from King’s College London’s Institute 
of Psychiatry and the South London 
and Maudsley NHS Foundation Trust on 
PROTECT (Provider Responses, Treatment, 
and Care for Trafficked People), a major 
research programme on human trafficking 
funded by the Department of Health. 
This will provide evidence to inform the 
NHS response to human trafficking, 
specifically in the identification and 
referral of trafficked people, and safe 
and appropriate care to meet their health 
needs. 
Drug use and 
Hepatitis C 
School researchers 
led by Tim Rhodes 
are investigating the 
prevention and treatment 
of hepatitis C in the UK. 
This has involved surveillance 
work in collaboration with HPA, 
but more substantially qualitative 
work with people who inject 
drugs and with young people in HIV 
treatment. 
A key finding is that hepatitis C protective 
practices were motivated not necessarily 
by harm reduction messages or concerns 
about hepatitis C acquisition, but by more 
immediate pragmatic concerns, such as 
avoiding drug withdrawal and maintaining 
venous access and care. These findings 
signal the need for a shift in harm reduction 
research and intervention from a risk and 
deficit focus to one that attends to the 
pragmatic concerns and everyday practices 
of people who inject drugs which may have 
preventive effects. 
A WHO-funded study in the UK explores the 
systemic and structural factors shaping 
treatment engagement, and points towards 
the delivery of hepatitis C treatment in drug 
and alcohol settings rather than hospitals, 
as a means of building trusting relationships 
between patients and providers. 
Professor David Heymann 
is chair of Public Health 
England, Head of the Centre 
on Global Health Security 
at Chatham House, and 
professor of epidemiology 
of infectious disease at the 
School. He has worked in 
the area of public health for 
over 35 years, for the US 
Centers for Disease Control 
and Prevention and with the 
World Health Organization.
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Translational research on 
infectious diseases 
The School is engaged in a major 
partnership with University College 
London to develop a world-leading centre 
for translational research on infectious 
diseases. With over 200 scientists currently 
working in translational and clinically 
applied infection research, the Bloomsbury 
Research Institute is already one of the 
largest concentrations of infectious disease 
researchers in Europe. 
The Institute’s mission is to seek new 
diagnostic tools, treatments and vaccines 
for pathogens ranging from the ‘big three 
killers’ HIV, TB and malaria, to neglected 
diseases including sleeping sickness, 
dengue fever and leishmaniasis, for which 
new diagnostics and treatments are urgently 
needed. It will also focus on the growing 
problem of hospital-acquired infections, 
which cause thousands of deaths in the UK 
and globally. 
Electronic Healthcare 
Records revolutionising 
research
The increasing availability of Electronic 
Healthcare Records is revolutionising 
health research. The School has a diverse 
programme of work using the UK Clinical 
Practice Research Datalink, a large 
collection of primary care medical records, 
and other data such as Hospital Episode 
Statistics and Medicare data from the USA. 
Researchers led by Liam Smeeth and 
Harriet Forbes have used these records to 
show how statins, widely used cholesterol-
lowering drugs, also reduce the risk of death 
among people with pneumonia. Linking 
medical records with temperature data, they 
demonstrated that a substantial short term 
risk of myocardial infarction is associated 
with colder outdoor temperatures. Ongoing 
work includes the long-term outcome of 
weight-loss surgery using Hospital Episode 
Statistics data; links between commonly 
prescribed drugs and cancer risk; and 
investigating the roles of temperature 
and pollution on exacerbations of chronic 
obstructive pulmonary disease. 
The School is playing a key role in a new 
Centre for Health service and Academic 
Partnership in Translational E-Health 
Research (CHAPTER), co-ordinated  by 
UCL Partners to harness the power of 
computerised data to improve patient care 
and public health.
Looking ahead: reform & innovation 
Climate change and health 
in the UK
The UK government has set specific targets 
for greenhouse gas emissions to lower the 
risk of dangerous climate change. Previous 
research at the School has shown that 
important health co-benefits could result 
from strategies targeting the domains of 
transport, built environment, and agriculture, 
for example through reduced fine particulate 
air pollution or a ‘low-carbon’ healthy diet. 
A recent study assesses the full general 
equilibrium economy-wide macroeconomic 
effects of health co-benefits from three 
similar UK strategies to meet locally specific 
2030 greenhouse gas emission targets. The 
method for measuring averted healthcare 
costs was published in The Lancet in 2012. 
Three scenarios were modelled: increased 
active travel in urban England and Wales, 
partial replacement of dietary saturated fat 
with polyunsaturates of plant origin and an 
assumed UK-wide improvement in home 
insulation and ventilation control. For all 
scenarios, the macroeconomic effects of 
health co-benefits are positive. 
Overall, substantial savings on health-care 
costs represent the main contributing 
factor (around £19 billion over 20 years). 
Increased labour supply also contributes 
positively.
Methodological research and 
innovation
If research is to be helpful for decision 
makers it is important that potential 
limitations with it are well understood. A 
recent ESRC study, led by Richard Grieve, 
aimed to extend current understanding of 
the relative merits of different analytical 
methods for reducing selection bias in 
health economic evaluations. Outputs 
have included a checklist for appraising 
alternative statistical approaches and 
workshops attended by researchers working 
in academia, the pharmaceutical industry 
and the governmental sector.
The future of public health 
Public Health England (PHE) offers a real opportunity 
to integrate public health leadership for England at 
national level across all aspects of health. There has 
been strong leadership in a number of specific areas, 
but never before in a single organisation with a remit 
to advocate for change wherever it is needed. 
PHE will strengthen primary prevention and public 
health in England in respect of communicable 
diseases, environmental hazards, and long term 
chronic conditions. It will also help to address 
the underlying causes of ill health including social 
determinants, which are beyond the scope of 
traditional health services. We will therefore be 
working hard to support local government in its new 
responsibilities for local health leadership. 
The London School of Hygiene & Tropical Medicine 
covers the full range of scientific disciplines relevant 
to public health, and we at PHE will draw on all these 
disciplines in our work, including basic epidemiology, 
molecular and social science, through to applied 
health services research, economics and behavioural 
science. Research within PHE will be anchored in 
academic environments as a means of ensuring peer 
review and expertise, ensuring our scientists are at 
the cutting edge of knowledge, as we continue to 
provide reference laboratory services for all major 
pathogens to the United Kingdom and, through our 
WHO Collaborating Centres, the world.
Operationally, PHE will bring together the expertise 
developed in surveillance, outbreak alert and 
response and chemical/nuclear safety with the 
challenges associated with promoting healthy 
lifestyles as a means of lengthening life without 
disability. Climate change and its effects are also a 
major concern, and the expertise of the School in 
this area will be vital. 
Public Health England has a leading role within the 
wider public health system. It will share its expertise 
and evidence with its partners – particularly in 
local government, the NHS, Clinical Commissioning 
Groups, and the voluntary and community sector 
– and this offers even more opportunity for vital 
collaboration. We are proud that many of our 
scientists have academic appointments at the 
School, and our partnership projects will help ensure 
we build our capacity to meet the challenges ahead 
with confidence. 
Support our work 
For more information about supporting our work in 
the UK, please contact: 
William Friar 
Head of Development 
London School of Hygiene & Tropical Medicine 
Keppel Street, London WC1E 7HT
Tel. +44 (0)20 7927 2630
Email william.friar@lshtm.ac.uk
Duncan Selbie is Chief 
Executive of Public Health 
England. He has worked 
in the NHS since 1980, 
in posts including Director 
General of Programmes and 
Performance, and Chief 
Executive roles at Hospital 
Trusts and Strategic Health 
Authority.
